We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$332M
Cap. Flow
+$245M
Cap. Flow %
12.29%
Top 10 Hldgs %
47.04%
Holding
78
New
21
Increased
16
Reduced
12
Closed
27

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$91M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$72.3M
3
A icon
Agilent Technologies
A
+$56.1M
4
ISRG icon
Intuitive Surgical
ISRG
+$52.5M
5
DHR icon
Danaher
DHR
+$50.1M

Top Sells

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$52.2M
2
VTRS icon
Viatris
VTRS
+$43M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$32.9M
4
MRK icon
Merck
MRK
+$32.4M
5
GILD icon
Gilead Sciences
GILD
+$32.1M

Sector Composition

Rank Sector Weight
1 Healthcare 73.01%
2 Financials 3.91%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
51
Abbott
ABT
$183B
– –
-99,000
Closed -$3.81M
ALNY icon
52
PUT
Alnylam Pharmaceuticals
ALNY
$27.5B
– –
-200,000
Closed -$13.4M
ARWR icon
53
Arrowhead Research
ARWR
$12.3B
– –
-450,000
Closed -$7.39M
BDX icon
54
Becton Dickinson
BDX
$45.6B
– –
-55,145
Closed -$6.3M
CNC icon
55
Centene
CNC
$30.1B
– –
-900,000
Closed -$14M
DVAX
56
DELISTED
Dynavax Technologies
DVAX
– –
-479,498
Closed -$8.67M
EXEL icon
57
CALL
Exelixis
EXEL
$14.1B
– –
-2,250,000
Closed -$7.96M
GLMD icon
58
Galmed Pharmaceuticals
GLMD
$4.95M
– –
-394
Closed -$814K
INCY icon
59
PUT
Incyte
INCY
$24.9B
– –
-450,000
Closed -$24.1M
ISRG icon
60
CALL
Intuitive Surgical
ISRG
$126B
– –
-1,080,000
Closed -$52.6M
MRK icon
61
CALL
Merck
MRK
$321B
– –
-786,000
Closed -$42.6M
MYGN icon
62
Myriad Genetics
MYGN
$507M
– –
-854,900
Closed -$29.2M
PFE icon
63
Pfizer
PFE
$142B
– –
-316,200
Closed -$9.64M
RMTI icon
64
Rockwell Medical
RMTI
$28M
– –
-1,003
Closed -$1.4M
SGMO
65
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-300,000
Closed -$5.42M
TENX icon
66
Tenax Therapeutics
TENX
$401M
– –
-47
Closed -$8.32M
VXRT
67
DELISTED
Vaxart
VXRT
– –
-104,545
Closed -$7.03M
SGEN
68
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-500,000
Closed -$22.8M
CLVS
69
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-475,000
Closed -$32.9M
ENDP
70
DELISTED
Endo International plc
ENDP
– –
-760,100
Closed -$52.2M
NUAN
71
DELISTED
Nuance Communications, Inc.
NUAN
– –
-1,674,750
Closed -$24.9M
FPRX
72
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-416,944
Closed -$8.2M
ESRX
73
DELISTED
Express Scripts Holding Company
ESRX
– –
-92,000
Closed -$6.91M
AEGR
74
CALL
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-300,000
Closed -$13.9M
AEGR
75
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-24,800
Closed -$1.15M
1 2
3
4

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q2 2014 Portfolio in Review

As of Q2 2014, HealthCor Management held 78 positions worth $1.99B, up 20% from $1.66B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

HealthCor Management deployed $245M of net new capital in Q2 2014, opening 21 new positions and adding to 16 existing holdings. Its largest new stake was Intuitive Surgical: 1,189,800 shares worth $54.4M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 65% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Viatris, an estimated $43M trimmed.

  • HealthCor Management's largest Q2 2014 buy was Intuitive Surgical: 1,189,800 shares worth $54.4M.
  • HealthCor Management added most to Allergan plc in Q2 2014, an estimated $91M increase.
  • HealthCor Management's biggest Q2 2014 reduction was Viatris, cutting an estimated $43M.
  • HealthCor Management fully exited Endo International plc in Q2 2014, selling an estimated $52.2M.
  • HealthCor Management's ten largest holdings make up 47% of its $1.99B portfolio in Q2 2014.
  • HealthCor Management opened 21 new positions and closed 27 in Q2 2014.
  • HealthCor Management's portfolio value rose 20% quarter-over-quarter to $1.99B.

Based on HealthCor Management's 13F filing for Q2 2014, filed 14 Aug 2014.